77 related articles for article (PubMed ID: 18392332)
21. Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?
Jung JH; Min PK; Kim JY; Park S; Choi EY; Ko YG; Choi D; Jang Y; Shim WH; Cho SY
Cardiology; 2005; 104(2):72-5. PubMed ID: 16020923
[TBL] [Abstract][Full Text] [Related]
22. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.
Strauss BH; Lau HK; Bowman KA; Sparkes J; Chisholm RJ; Garvey MB; Fenkell LL; Natarajan MK; Singh I; Teitel JM
Circulation; 1999 Oct; 100(15):1616-22. PubMed ID: 10517732
[TBL] [Abstract][Full Text] [Related]
23. Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis.
Hojo Y; Ikeda U; Mizuno O; Katsuki TA; Shimada K
Int J Cardiovasc Intervent; 2003; 5(4):190-4. PubMed ID: 14630561
[TBL] [Abstract][Full Text] [Related]
24. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
25. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
26. Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA.
Prisco D; Fedi S; Antonucci E; Capanni M; Chiarugi L; Chioccioli M; Falai M; Giglioli C; Abbate R; Gensini GF
Thromb Res; 2001 Nov; 104(3):181-6. PubMed ID: 11672760
[TBL] [Abstract][Full Text] [Related]
27. Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.
Chung CM; Nakamura S; Tanaka K; Tanigawa J; Kitano K; Akiyama T; Matoba Y; Katoh O
Heart Vessels; 2004 Sep; 19(5):213-20. PubMed ID: 15372295
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
29. An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation.
Bayata S; Arıkan E; Yeşil M; Postacı N; Taş A; Köseoğlu M
Anadolu Kardiyol Derg; 2010 Oct; 10(5):405-9. PubMed ID: 20929696
[TBL] [Abstract][Full Text] [Related]
30. Impact of operator volume on overall major adverse cardiac events following direct coronary stent implantation versus stenting after predilatation.
IJsselmuiden S; Kiemeneij F; Tangelder G; Slagboom T; van der Wieken R; Serruys P; Laarman G
Int J Cardiovasc Intervent; 2004; 6(1):5-12. PubMed ID: 15204167
[TBL] [Abstract][Full Text] [Related]
31. [Results of coronary stenting in relation to the length of an implanted stent].
Puretskiĭ MB; Abugov SA; Saakian IuM
Vestn Rentgenol Radiol; 2003; (1):36-42. PubMed ID: 12776505
[TBL] [Abstract][Full Text] [Related]
32. Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial.
Dibra A; Kastrati A; Mehilli J; Pache J; von Oepen R; Dirschinger J; Schömig A
Catheter Cardiovasc Interv; 2005 Jul; 65(3):374-80. PubMed ID: 15926182
[TBL] [Abstract][Full Text] [Related]
33. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.
Inoue T; Sata M; Hikichi Y; Sohma R; Fukuda D; Uchida T; Shimizu M; Komoda H; Node K
Circulation; 2007 Feb; 115(5):553-61. PubMed ID: 17261663
[TBL] [Abstract][Full Text] [Related]
34. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P
Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512
[TBL] [Abstract][Full Text] [Related]
35. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
Silber S; Hamburger J; Grube E; Pfisterer M; Belardi J; Webb J; Zmudka K; Nienaber C; Hauptman K; Rutsch W; Dawkins K; Drzewiecki J; Koglin J; Colombo A
Herz; 2004 Mar; 29(2):171-80. PubMed ID: 15057438
[TBL] [Abstract][Full Text] [Related]
36. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
[TBL] [Abstract][Full Text] [Related]
37. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
[TBL] [Abstract][Full Text] [Related]
38. Preprocedural statin administration can reduce thrombotic reaction after stent implantation.
Nishino M; Hoshida S; Kato H; Egami Y; Shutta R; Yamaguchi H; Tanaka K; Tanouchi J; Hori M; Yamada Y
Circ J; 2008 Feb; 72(2):232-7. PubMed ID: 18219159
[TBL] [Abstract][Full Text] [Related]
39. Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours.
Gyöngyösi M; Strehblow C; Sperker W; Hevesi A; Garamvölgyi R; Petrási Z; Pavo N; Ferdinandy P; Csonka C; Csont T; Sylvèn C; Declerck PJ; Pavo I; Wojta J; Glogar D; Huber K
Thromb Haemost; 2006 Aug; 96(2):202-9. PubMed ID: 16894465
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory mechanisms of adverse reactions to BMS.
Toutouzas K; Karanasos A; Stefanadis C
Curr Vasc Pharmacol; 2013 Jul; 11(4):379-91. PubMed ID: 23905633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
